Why Is Summit Therapeutics Inc. (NASDAQ: SMMT) Stock Down Today?

Summit Therapeutics Inc. (NASDAQ: SMMT) Summary

Summit Therapeutics Inc. (NASDAQ: SMMT) is trading up +4.96% at $18.42, reflecting a positive shift in investor sentiment today. The stock opened at $18.07 and has moved between $17.97 and $18.83 so far.

Trading volume is 7053570, which is 38% above its average, and the price action suggests buying interest.

Technically, SMMT on the NASDAQ is trading above its 50-day moving average of $14.46 and above its 200-day moving average of $16.43, indicating short-term and long-term strength.

Analyst sentiment is bullish. Meyka's AI assigns SMMT a grade of B (Overall moderate), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of +19.27% in 1 month ($21.97), -28.06% in 1 year ($13.25), and -100.00% in 5 years ($0.00).

See full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement on the NASDAQ.
Stay informed and make better investment decisions.